BU BÖLÜM HAKKINDA
The Biden administration faces a variety of issues when it comes to China, from trade policy to aggression in the South China Sea. Not to be overlooked, however, is how the new administration will handle China's policies and practices regarding intellectual property.
In this live podcast, experts from across the political spectrum discuss the key considerations at play regarding China and intellectual property and debate the best path forward for the new administration.
Featuring:
- Mark Cohen, Director and Senior Fellow, Berkeley Center for Law and Technology, University of California at Berkeley
- Justin Hughes, Hon. William Matthew Byrne, Jr. Chair Professor of Law, Loyola Law School, Loyola Marymount University
- [Moderator] Brian O'Shaughnessy, Partner, Dinsmore & Shohl LLP
Visit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.
In this live podcast, experts from across the political spectrum discuss the key considerations at play regarding China and intellectual property and debate the best path forward for the new administration.
Featuring:
- Mark Cohen, Director and Senior Fellow, Berkeley Center for Law and Technology, University of California at Berkeley
- Justin Hughes, Hon. William Matthew Byrne, Jr. Chair Professor of Law, Loyola Law School, Loyola Marymount University
- [Moderator] Brian O'Shaughnessy, Partner, Dinsmore & Shohl LLP
Visit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.
ingilizce
Amerika Birleşik Devletleri
BU BÖLÜMDE
TRANSKRİPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SON BÖLÜMLERİ ARA
RTP's Fourth Branch Podcast için geçmiş bölümleri ara.
BU PODCAST'IN DİĞER BÖLÜMLERİ
On January 17, the Biden-Harris Administration added 15 new drugs, including Ozempic, to the list of drugs covered by the Medicare Drug Price Negotiation Program of the Inflation Reduction Act (IRA). Now there are a total of 25 drugs that are covered by the IRA’s requirement that the Depa…
America’s new AI Action Plan — announced by the White House in July and framed by three pillars of accelerating innovation, building national AI infrastructure, and projecting U.S. leadership abroad — promises more than 90 separate federal actions, from fast-tracking a…
On July 1st, 2025, the Office of Federal Contract Compliance Programs (OFCCP) released three proposed regulatory changes, two of which would have significant implications for federal contractor’s legal obligations surrounding affirmative action and disability inclusion. In this episode, exper…
On June 27th, the Supreme Court ruled in Free Speech Coalition v. Paxton that Texas’s age-verification law did not violate the First Amendment's Free Speech Clause. Justice Thomas wrote the Court’s opinion, holding that States had a right to protect children from obscenity, even…
Smaller, advanced technology entrepreneurs are increasingly shaping the U.S. innovation landscape through what some have called the “Little Tech Agenda.” But what exactly is this agenda, and how might it influence policy debates moving forward?America has long celebrated small-s…
Feragatname: Bu sayfaya yerleştirilmiş podcast ve sanat eserleri, sahibinin mülkiyetinde olan ve Listen Notes, Inc.'e bağlı olmayan veya tarafından onaylanmayan The Federalist Society'e aittir.
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
